Project #1
Title: Serum zinc-alpha2-glycoprotein (ZAG) as a biomarker of coronary artery atherosclerosis.
Objectives: To estimate the serum levels of zinc-alpha2-glycoprotein (ZAG) and adiponectin in the general population and in patients with established ischemic heart disease and to investigate the correlation of ZAG and adiponectin with traditional cardiovascular risk factors.
Department: Department of Population Medicine and Lifestyle Diseases Prevention
Supervisor: prof. Karol Kamiński, MD-PhD
Co-investigator: Jacek Jamiołkowski, MD-PhD, Eng.
Project #2
Title: Untargeted metabolomic profiling of exhaled breath condensate (breathomics / volatolomics) of electronic cigarette smokers (vapers), smokers and non-smokers from the general population.
Objectives: To perform untargeted metabolomic profiling of exhaled breath condensate (breathomics / volatolomics) of electronic cigarette smokers (vapers), smokers and non-smokers from general population and to carry out a comprehensive study of metabolites according to to smoking/vaping status as well as other pathophysiological measurements.
Department: Department of Population Medicine and Lifestyle Diseases Prevention; Centre for Clinical Research
Supervisor: prof. Karol Kamiński, MD-PhD
Co-investigators: Joanna Godzien, MD-PhD; Jacek Jamiołkowski, MD-PhD, Eng.; prof. Krzysztof Kowal, MD-PhD
Research background: Rama Krishna Guggilla is a General Practitioner (Family Medicine Specialist) and Clinical Epidemiologist with experience in clinical, public health and health services research. He successfully conducted three research studies as an investigator, three research studies as a Research Fellow, and three clinical trials in cardiovascular, diabetes and vaccines therapeutic areas as a Medical Monitor.
Research interests: His current research interests include new and emerging risk factors for cardiovascular and kidney diseases, obesity and diabetes; systems-level analysis of high-throughput data.